Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeFirst stated

Joint Research With Veneno Technologies on an Ion Channel Therapeutic

First written in FY2025. . Latest entry: FY2025.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Joint research with Veneno Technologies to develop novel ion channel therapeuticsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025First statedAnnual report

    「また、2025年１月にVeneno Technologies株式会社と新規イオンチャネル治療薬開発のための共同研究契約を締結しています。」

    Veneno Technologies株式会社と、新規イオンチャネル治療薬開発を目的とする共同研究契約を2025年1月に締結した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.